BY MED-TECH WORLD
The cannabis industry is one that has traditionally been fraught with regulatory hurdles, gray areas and ethical pot holes. It is refreshing to finally reap the results of long discussions and negotiations between all those involved and see this industry flourish across countries, as more and more countries lift their restrictions and new businesses move into play.
From seed-to-sale tracking to personal, patient-based medical products, the convergence of these two spheres promises great things for the future of medical cannabis, something we’re sure many of the investors attending our summits will be keen to explore.
This same shift is also alluring for the hope it brings to patients suffering from chronic illnesses, something which we have been very keen to explore in our past editions. Patients too deserve to have their thoughts heards and wishes served.
SiGMA, being a pioneer in the Medical-Cannabis Conference Industry was very adamant to continue hosting this vertical, in parallel with Malta’s perseverance to build its own flourishing Medical Cannabis Industry and as a result, will continue to host this during the Malta Week two-day summit, with a separate stage solely dedicated to medical cannabis and other related topics, including the rise of psychedelics.